• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性尿毒症缩短时间方案中的血液灌流。长期结果。

Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results.

作者信息

Stefoni S, Colì L, Feliciangeli G, Scolari M P, Bonomini V

出版信息

Int J Artif Organs. 1986 Sep;9(5):297-300.

PMID:3781660
Abstract

This paper reports the Authors' 8 year experience in the clinical use of charcoal hemoperfusion as a means to reduce the weekly time of treatment in chronic uremic patients. Two different programmes were applied. Programme A (34 patients) which involved substituting the 3 procedures per week of standard dialysis (4 hours duration each) by 2 procedures of combined hemodialysis and hemoperfusion, again of 4 hours duration each. Programme B (18 patients) which involved substituting the 3 procedures per week of 4 hours duration by 3 procedures of 3 hours each, 2 of combined hemodialysis and hemoperfusion, 1 of conventional dialysis. The net weekly reduction was 33% for Programme A and 25% for Programme B. The efficacy of the two Programmes was evaluated by clinical, hematochemical, nutritional and instrumental parameters.

摘要

本文报告了作者在将活性炭血液灌流作为减少慢性尿毒症患者每周治疗时间的一种手段的临床应用方面的8年经验。应用了两种不同的方案。方案A(34例患者),即每周将3次标准透析(每次4小时)替换为2次血液透析和血液灌流联合治疗,每次同样为4小时。方案B(18例患者),即每周将3次每次4小时的治疗替换为3次每次3小时的治疗,其中2次为血液透析和血液灌流联合治疗,1次为常规透析。方案A每周净减少33%,方案B每周净减少25%。通过临床、血液化学、营养和仪器参数对两种方案的疗效进行了评估。

相似文献

1
Hemoperfusion in reduced-time programmes for chronic uremia. Long-term results.慢性尿毒症缩短时间方案中的血液灌流。长期结果。
Int J Artif Organs. 1986 Sep;9(5):297-300.
2
Use of combined hemodialysis/hemoperfusion in chronic uremia.血液透析联合血液灌流在慢性尿毒症中的应用。
Contrib Nephrol. 1982;29:123-32. doi: 10.1159/000406184.
3
Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.我们在慢性尿毒症患者中联合进行血液透析-血液灌流治疗的经验。
Biomater Artif Cells Artif Organs. 1987;15(1):175-81. doi: 10.3109/10731198709118517.
4
Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.血液透析联合血液灌流治疗可缩短慢性尿毒症替代治疗时间。
Int J Artif Organs. 1981 Jul;4(4):186-91.
5
Present status of hemoperfusion/hemodialysis in Italy.意大利血液灌流/血液透析的现状
Appl Biochem Biotechnol. 1984;10:157-66. doi: 10.1007/BF02783748.
6
Combined hemoperfusion/hemodialysis in the treatment of uremic patients with vascular access problems: case reports.血液灌流联合血液透析治疗有血管通路问题的尿毒症患者:病例报告
Int J Artif Organs. 1986 Sep;9(5):309-12.
7
Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
Contrib Nephrol. 1982;29:133-42. doi: 10.1159/000406185.
8
Regular hemoperfusion in regular dialysis treatment. A long-term study.
Int J Artif Organs. 1980 Nov;3(6):348-53.
9
Aluminum removal with hemodialysis, hemofiltration and charcoal hemoperfusion in uremic patients after desferrioxamine infusion. A comparison of efficiency.去铁胺输注后尿毒症患者采用血液透析、血液滤过和活性炭血液灌流进行铝清除。效率比较。
Nephron. 1989;51(3):325-9. doi: 10.1159/000185317.
10
Evaluation of a new coated charcoal for hemoperfusion in uremia.一种用于尿毒症血液灌流的新型包膜活性炭的评估。
Int J Artif Organs. 1979 Nov;2(6):320-3.